newsfilter
← Latest News
Business Wire·

Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Conference Call and Webcast at 8:30 a.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and twelve months ended December 31, 2023, and provided an